Larger studies are needed to back the use of nailfold capillaroscopy — a non-invasive technique for imaging tiny blood vessels in the fingers — for…
hATTR-PN
Alnylam Pharmaceuticals has selected Orsini Specialty Pharmacy to distribute Amvuttra (vutrisiran), which was recently approved by the U.S. Food and Drug Administration (FDA)…
HATTR-PN
ColumnsLike David Attenborough, I Want to Use My Voice to Make a Difference
I recently watched a documentary narrated by British naturalist David Attenborough about how climate change and deforestation negatively affect animal life on our…
A total of 30 patient advocacy groups working to further understanding and the needs of people living with rare diseases have been selected to receive…
HATTR-PN
ColumnsI Learned the True Value of Friendship Amid Difficult Times
“Lots of people want to ride with you in the limo, but what you want is someone who will take the bus with you when…
Members of a Chinese family carrying a rare gene mutation causing familial amyloid polyneuropathy (FAP) experienced abnormal protein deposits in the eye — manifesting…
Nonprofits, scientists, governmental organizations, and the rare disease drug development industry have long cited 7,000 as the average…
HATTR-PN
ColumnsAppreciating Challenges Can Help Partners Form a Special Bond
I lost my husband, Aubrey, on May 22. This period of adapting to him being gone has been somewhat challenging for me. Although I…
A one-time treatment with NTLA-2001, Intellia Therapeutics’ experimental gene-editing therapy for people with familial amyloid polyneuropathy (FAP) and other types of ATTR amyloidosis, continued…
HATTR-PN
ColumnsThe Importance of Thinking in Advance About End-of-life Arrangements
If you are new to my column, my name is Jaime, and I was a caregiver to my husband, Aubrey, until he passed…
Recent Posts
- Mental flexibility is key to coping with my role as a caregiver
- Starting Attruby early cuts heart-related risks by half in ATTR-CM
- Amvuttra effective in East Asian patients with hATTR-PN: Trial data
- The long journey to an amyloidosis diagnosis can be full of setbacks
- Physically demanding jobs linked to higher risk of wild-type ATTR-CM